Hedgehog antagonist GDC‐0449 is effective in the treatment of advanced basal cell carcinoma

GDC-0449 showed significant inhibitory activity in the treatment of advanced basal cell carcinoma.

Page 1

	Year	Citations
Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006 Howard W. Rogers, Martin A. Weinstock, Ashlynne R. Harris, Archives of Dermatology	2010	1.2K
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma Daniel D. Von Hoff, Patricia LoRusso, Charles M. Rudin, New England Journal of Medicine	2009	1.1K
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449 Charles M. Rudin, Christine L. Hann, John Laterra, New England Journal of Medicine Neuro-oncologyTumoral PathologyHedgehog SignalingTumor SpecimensMalignant Disease	2009	1K
The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas Mae R. Gailani, Mona Ståhle‐Bäckdahl, David J. Leffell, Nature Genetics ChromatinLineage PlasticityCell LineageDevelopmental BiologyMedicine	1996	771
Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp Yimao Zhang, John Laterra, Martin G. Pomper Neoplasia	2009	74
Hedgehog Drugs Begin To Show Results K. Garber JNCI Journal of the National Cancer Institute Preclinical Drug EvaluationMedicineHedgehog Drugs BeginPharmacotherapyDrug Development	2008	28

Page 1